Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6379327 | 0.91 | TK1 (0.67) | TK1DHFR | |
| SCHEMBL30995894 | 0.89 | TK1 (0.62) | TK1DHFR | |
| SCHEMBL19308099 | 0.89 | TK1 (0.65) | TK1DHFR | |
| SCHEMBL27054363 | 0.89 | TK1 (0.65) | TK1DHFR | |
| SCHEMBL658884 | 0.89 | TK1 (0.65) | TK1DHFR | |
| SCHEMBL24420522 | 0.89 | TK1 (0.65) | TK1DHFR | |
| SCHEMBL316663 | 0.89 | TK1 (0.65) | TK1DHFR | |
| SCHEMBL7537554 | 0.89 | TK1 (0.65) | TK1DHFR | |
| SCHEMBL3272720 | 0.88 | TK1 (0.63) | TK1DHFR | |
| SCHEMBL2295 | 0.88 | TK1 (0.63) | TK1DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2638048-A1 | NUCLEIC ACIDSBUILDING BLOCKS AND METHODS FOR THE SYNTHESIS OF 5-HYDROXYMETHYLCYTOSINE-CONTAINING | Ludwig-Maximilians-Universität München (DE) | 2013-09-18 | — | — | EP | disclosed |
| US-20130237697-A1 | BUILDING BLOCKS AND METHODS FOR THE SYNTHESIS OF 5-HYDROXYMETHYLCYTOSINE-CONTAINING NUCLEIC ACIDS | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) | 2013-09-12 | — | — | US | disclosed |
| WO-2012062907-A1 | NUCLEIC ACIDSBUILDING BLOCKS AND METHODS FOR THE SYNTHESIS OF 5-HYDROXYMETHYLCYTOSINE-CONTAINING | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2012-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130237697-A1 | BUILDING BLOCKS AND METHODS FOR THE SYNTHESIS OF 5-HYDROXYMETHYLCYTOSINE-CONTAINING NUCLEIC ACIDS | RNGTT, NSUN2, NT5C3B | TK1 411/4885DHFR 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.